Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone

Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4.

Osteoporosis: Zoledronic acid increases bone mineral density and reduces fracture rate

Asian Pac J Trop Med. 2012 Sep;5(9):743-8. doi: 10.1016/S1995-7645(12)60118-7

Zoledronic acid reduces number of skeletal-related events in new multiple myeloma patients

Lancet Oncol. 2011 Aug;12(8):743-52. doi: 10.1016/S1470-2045(11)70157-7. Epub 2011 Jul 21

Early vs standard zoledronic acid treatments for prostate cancer metastatic to bone

J Clin Oncol. 2014 Apr 10;32(11):1143-50. doi: 10.1200/JCO.2013.51.6500.

Zoledronic acid for postmenopausal osteoporosis reduces fracture risk and improves BMD

J Bone Miner Metab. 2011 May;29(3):328-33. doi: 10.1007/s00774-010-0223-y. Epub 2010 Oct 5

Zoledronic acid reduces rates of new clinical fractures after hip fracture repair

N Engl J Med. 2007 Nov 1;357(18):1799-809. Epub 2007 Sep 17

Zoledronic acid reduces early implant migration in total hip arthroplasty

J Bone Joint Surg Am. 2009 Feb;91(2):274-81

WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy

Zoledronic acid given upfront maintains BMD in postmenopausal breast cancer patients

Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10

Increase in BMD with zoledronic acid in elderly women with osteoporosis and living in LTC

JAMA Intern Med. 2015 Jun;175(6):913-21

Zoledronic acid in the prevention and treatment of glucocorticoid-induced osteoporosis

Lancet. 2009 Apr 11;373(9671):1253-63

Denosumab noninferior to zoledronic acid in the treatment of bone metastasis

J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22

Annual infusion of zoledronic acid reduces days of back pain, disability, and bed rest

J Bone Miner Res. 2011 May;26(5):984-92. doi: 10.1002/jbmr.292

Efficacy of zoledronic acid following PLIF in patients with osteoporosis

Osteoporos Int. 2016 Apr;27(4):1469-76

Zoledronic acid increases BMD and prevents fracture risks in women with osteoporosis

J Int Med Res. 2013 Jun;41(3):697-704. doi: 10.1177/0300060513480917. Epub 2013 May 13

Prostate cancer: Zoledronic acid as an adjuvant therapy is well-tolerated and improves BMD

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):382-6. doi: 10.1038/pcan.2013.35. Epub 2013 Oct 1

Postoperative zoledronic acid has no effect on healing after Lapidus arthrodesis and Akin osteotomy

J Int Med Res. 2018 Aug;46(8):3251-3261. doi: 10.1177/0300060518760128

Zoledronic Acid increased hip BMD in acute Charcot neuroarthropathy

Foot Ankle Surg. 2013 Jun;19(2):121-4. doi: 10.1016/j.fas.2012.12.007. Epub 2013 Feb 20

Zoledronic acid: best overall bisphosphonate treatment for osteoporosis fractures

Semin Arthritis Rheum. 2011 Feb;40(4):275-84.e1-2.

Zoledronic acid affects men and women similarly in increasing bone mass after hip fracture

J Am Geriatr Soc. 2011 Nov;59(11):2084-90. doi: 10.1111/j.1532-5415.2011.03666.x. Epub 2011 Oct 21